cms decision in us , page-10

I am expecting the European trials to finish in 2004 and commercialisation sometime in 2005 as VCR has mentioned.

The approval for medicare will also affect the VCR price as soon as it comes in.

The reason is simply this that the attraction for a take-over of VCR increases regardless of VCR being in commercial business or not. (When the tide comes in, all ships rise).

That is commercial logic. Had the approval been given last night then the share price would have gone easily over $2.30 and may even have strengthened further.

Gerry